𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genotype–phenotype correlation in von Hippel-Lindau families with renal lesions

✍ Scribed by Catherine Gallou; Dominique Chauveau; Stéphane Richard; Dominique Joly; Sophie Giraud; Sylviane Olschwang; Natacha Martin; Céline Saquet; Yves Chrétien; Arnaud Méjean; Jean-Michel Correas; Gérard Benoît; Pierre Colombeau; Jean-Pierre Grünfeld; Claudine Junien; Christophe Béroud

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
141 KB
Volume
24
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotype–phenotype correlation in von Hi
Genotype–phenotype correlation in von Hippel-Lindau families with renal lesions
✍ Catherine Gallou; Dominique Chauveau; Stéphane Richard; Dominique Joly; Sophie G 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

von Hippel-Lindau (VHL) disease arises from mutations in the VHL gene and predisposes patients to develop a variety of tumors in different organs. In the kidney, single or multiple cysts and renal cell carcinomas (RCC) may occur. Both inter- and intrafamilial heterogeneity in clinical expression are

Genotype–phenotype correlations in von H
Genotype–phenotype correlations in von Hippel-Lindau disease
✍ Kai Ren Ong; Emma R. Woodward; Pip Killick; Caron Lim; Fiona Macdonald; Eamonn R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Communicated by David N. Cooper von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome resulting from mutations in the VHL tumor suppressor gene. VHL disease displays marked variation in expression and the presence of pheochromocytoma has been linked to missense VHL mutat

Genotype–phenotype correlations of pheoc
Genotype–phenotype correlations of pheochromocytoma in two large von Hippel–Lindau (VHL) type 2A kindreds with different missense mutations
✍ Sarah M. Nielsen; Wendy S. Rubinstein; Darcy L. Thull; Michaele J. Armstrong; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract Von Hippel–Lindau (VHL) disease type 2A is an inherited tumor syndrome characterized by predisposition to pheochromocytoma (pheo), retinal hemangioma (RA), and central nervous system hemangioblastoma (HB). Specific VHL subtypes display genotype–phenotype correlations but, unlike other f

Mutation screening and genotype-phenotyp
Mutation screening and genotype-phenotype correlation in 32 families with Wilson disease
✍ Muriel Bost; Alain Lachaux; Michèle Accominotti; Antoon Vandenberghe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

Wilson disease (WD) is an autosomal recessive disorder of copper transport, manifesting as chronic liver disease and/or neurologic impairment due to accumulation of copper in several tissues, principally the liver and the brain. The WD gene encodes a copper transporting P-type ATPase that is defecti

Vascular endothelial growth factor overe
Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma
✍ Hiroshi Igarashi; Mariko Esumi; Hajime Ishida; Kiyoki Okada 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND A high frequency of genetic alterations of the von Hippel‐Lindau (__VHL)__ gene and overexpression of the vascular endothelial growth factor (__VEGF)__ gene have been observed independently in human sporadic renal cell carcinoma (RCCs), but to the authors' knowledge the a

Somatic von Hippel–Lindau disease gene m
Somatic von Hippel–Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney
✍ Minoru Yoshida; Masahiro Yao; Isao Ishikawa; Takeshi Kishida; Yoji Nagashima; Ke 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

## Abstract It has been documented that renal cell carcinomas (RCCs) occur frequently in patients treated with long‐term dialysis, especially in cases of end‐stage renal disease (ESRD)/acquired cystic disease of the kidney (ACDK). To address the molecular pathogenesis of ESRD/ACDK‐associated RCCs,